These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31517995)

  • 1. Genetic Predisposition to Anticonvulsant Hypersensitivity.
    Pirmohamed M
    Clin Pharmacol Ther; 2019 Nov; 106(5):919-922. PubMed ID: 31517995
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of HLA genotypes with phenobarbital hypersensitivity in children.
    Manuyakorn W; Mahasirimongkol S; Likkasittipan P; Kamchaisatian W; Wattanapokayakit S; Inunchot W; Visudtibhan A; Wichukchinda N; Benjaponpitak S
    Epilepsia; 2016 Oct; 57(10):1610-1616. PubMed ID: 27554620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.
    Israel S; Maggio N; Ekstein D; Zaid H; Firer M; Bederovsky Y; Noyman I; Gandelman-Marton R; Blatt I; Brautbar C; Marom E; Nahlieli Dil D; Berman E; Sabag D; Ingber A; Eyal S
    Epilepsia; 2016 Oct; 57(10):e205-e209. PubMed ID: 27527795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypersensitivity syndrome reactions to antiepileptic drugs, clinical characteristic and association with HLA-B*1502].
    Sun D; Shi YW; Liu ZS; Liao WP; Wang FL; Wu GF; Hu JS; He CY
    Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(39):2763-6. PubMed ID: 21162913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine-induced hypersensitivity syndrome in a Han Chinese patient with the HLA-B 5801 genotype.
    Chow JC; Huang CW; Fang CW; Wu YJ; Tsai JJ
    Neurol Sci; 2013 Jan; 34(1):117-9. PubMed ID: 22258364
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.
    Büyüköztürk S; Kekik Ç; Gökyiğit AZ; Tezer Filik FI; Karakaya G; Saygi S; Dursun AB; Kirbaş S; Tüfekçi A; Sin AZ; Aydoğdu I; Sorgun MH; Aydin N; Gelincik A; Çolakoğlu B; Çelik G; Oğuz F
    Eur Ann Allergy Clin Immunol; 2018 Jan; 50(1):36-41. PubMed ID: 29350020
    [No Abstract]   [Full Text] [Related]  

  • 7. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Chang WC; Hung SI; Carleton BC; Chung WH
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):723-734. PubMed ID: 32510242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.
    Su SC; Chen CB; Chang WC; Wang CW; Fan WL; Lu LY; Nakamura R; Saito Y; Ueta M; Kinoshita S; Sukasem C; Yampayon K; Kijsanayotin P; Nakkam N; Saksit N; Tassaneeyakul W; Aihara M; Lin YJ; Chang CJ; Wu T; Hung SI; Chung WH
    Clin Pharmacol Ther; 2019 Feb; 105(2):476-485. PubMed ID: 30270535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe drug-induced hypersensitivity syndrome with a shared HLA-B allele.
    Harding DJ; Subramaniam K; MacQuillan G; Davis J; Nolan D
    Med J Aust; 2012 Oct; 197(7):411-3. PubMed ID: 23025739
    [No Abstract]   [Full Text] [Related]  

  • 11. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs.
    Manson LEN; Nijenhuis M; Soree B; de Boer-Veger NJ; Buunk AM; Houwink EJF; Risselada A; Rongen GAPJM; van Schaik RHN; Swen JJ; Touw DJ; van Westrhenen R; Deneer VHM; Guchelaar HJ
    Eur J Hum Genet; 2024 Aug; 32(8):903-911. PubMed ID: 38570725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive genotype.
    Ito S; Carleton BC
    CMAJ; 2010 May; 182(8):804. PubMed ID: 20479057
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework.
    Plumpton CO; Pirmohamed M; Hughes DA
    Clin Pharmacol Ther; 2019 Jun; 105(6):1429-1438. PubMed ID: 30466189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir.
    Agundez JA; Esguevillas G; Amo G; Garcia-Martin E
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):151. PubMed ID: 25891395
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
    JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
    Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
    Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-B*5701 and hypersensitivity reactions to abacavir. Study methods and clinical relevance].
    Arnedo Valero M
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():34-9. PubMed ID: 18680694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA Alleles B*0801 and DRB1*0301 Are Associated with Dermatitis Herpetiformis in a Chinese Population.
    Sun Y; Lin Y; Yang B; Wang C; Fu X; Bao F; Yu G; Zhang Q; Wang Z; Zhou G; Chen X; Wu M; Wang G; Liu H; Liu J; Zhang F
    J Invest Dermatol; 2016 Feb; 136(2):530-532. PubMed ID: 26967484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.